REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $117,827 | +23.0% | 741 | +9.5% | 0.03% | +17.4% |
Q2 2023 | $95,769 | +511.6% | 677 | +628.0% | 0.02% | +475.0% |
Q1 2023 | $15,658 | -3.7% | 93 | -3.1% | 0.00% | -20.0% |
Q4 2022 | $16,254 | -4.4% | 96 | +7.9% | 0.01% | 0.0% |
Q3 2022 | $17,000 | – | 89 | +4350.0% | 0.01% | – |
Q2 2022 | $0 | – | 2 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 2 | +100.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 1 | -98.4% | 0.00% | -100.0% |
Q2 2019 | $5,000 | +25.0% | 62 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $4,000 | +100.0% | 62 | +106.7% | 0.00% | 0.0% |
Q4 2018 | $2,000 | 0.0% | 30 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $2,000 | +100.0% | 30 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 30 | +87.5% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | – | 16 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |